NS6180
NS6180 is a new orally active KCa3.1 channel inhibitor. NS6180 inhibits cloned human KCa3.1 channels with an IC50value of 9 nM. NS6180 can be used for the research of inflammatory bowel disease (IBD) [1].
Product Specifications
CAS Number
353262-04-1
UNSPSC
12352005
Hazard Statement
H317, H411
Target
Potassium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/NS6180.html
Purity
99.76
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C1CSC2=CC=CC=C2N1CC3=CC=CC(C(F)(F)F)=C3
Molecular Formula
C16H12F3NOS
Molecular Weight
323.34
Precautions
H317, H411
References & Citations
[1]Strobak D, et al. NS6180, a new K (Ca) 3.1 channel inhibitor prevents T-cell activation and inflammation in a rat model of inflammatory bowel disease. Br J Pharmacol. 2013 Jan;168 (2) :432-44.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC421161 20 µg
beta Defensin 3 (DEFB103A) (NM_001081551) Human Over-expression Lysate
Sign In for Pricing
View Details 
